FDA Inspection 1091073 — Hans Biomed Corporation

Hans Biomed Corporation — FEI 3003828812

The FDA completed an inspection of Hans Biomed Corporation on April 5, 2019 in Yuseong District. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 5, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Yuseong District (Korea (the Republic of))